{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:37:07Z","timestamp":1784025427984,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA186086"],"award-info":[{"award-number":["R21CA186086"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA186086"],"award-info":[{"award-number":["R21CA186086"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10549-018-4736-8","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T12:52:37Z","timestamp":1520340757000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer"],"prefix":"10.1007","volume":"170","author":[{"given":"Marzana","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Euhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Onega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj K.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-4460","authenticated-orcid":false,"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"4736_CR1","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203\u20135209","journal-title":"J Clin Oncol"},{"key":"4736_CR2","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","volume":"27","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362\u20131367","journal-title":"J Clin Oncol"},{"key":"4736_CR3","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","volume":"29","author":"TA King","year":"2011","unstructured":"King TA, Sakr R, Patil S et al (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158\u20132164","journal-title":"J Clin Oncol"},{"key":"4736_CR4","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","volume":"17","author":"K Yao","year":"2010","unstructured":"Yao K, Stewart AK, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the national cancer data base, 1998\u20132007. Ann Surg Oncol 17:2554\u20132562","journal-title":"Ann Surg Oncol"},{"key":"4736_CR5","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1200\/JCO.2008.19.4225","volume":"27","author":"R Katipamula","year":"2009","unstructured":"Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082\u20134088","journal-title":"J Clin Oncol"},{"key":"4736_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","volume":"265","author":"SM Wong","year":"2016","unstructured":"Wong SM, Freedman RA, Sagara Y et al (2016) Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg 265:581\u2013589","journal-title":"Ann Surg"},{"key":"4736_CR7","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","volume":"29","author":"HB Nichols","year":"2011","unstructured":"Nichols HB, Berrington de Gonzalez A, Lacey JV et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564\u20131569","journal-title":"J Clin Oncol"},{"key":"4736_CR8","unstructured":"Uyeno L, Behrendt, Vito C (2012) Contralateral breast cancer: Impact on survival after unilateral breast cancer is stage-dependent. ASCO Breast Cancer Symposium Abstract vol 69"},{"key":"4736_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/jnci\/djm267","volume":"100","author":"L Bertelsen","year":"2008","unstructured":"Bertelsen L, Bernstein L, Olsen JH et al (2008) Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women\u2019s environment, cancer and radiation epidemiology study. J Natl Cancer Inst 100:32\u201340","journal-title":"J Natl Cancer Inst"},{"key":"4736_CR10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/jnci\/djp181","volume":"101","author":"AW Kurian","year":"2009","unstructured":"Kurian AW, McClure LA, John EM et al (2009) Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst 101:1058\u20131065","journal-title":"J Natl Cancer Inst"},{"key":"4736_CR11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1634\/theoncologist.2011-0022","volume":"16","author":"AM Brewster","year":"2011","unstructured":"Brewster AM, Parker PA (2011) Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer. Oncologist 16:935\u2013941","journal-title":"Oncologist"},{"key":"4736_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10549-010-1137-z","volume":"127","author":"C Bouchardy","year":"2011","unstructured":"Bouchardy C, Benhamou S, Fioretta G et al (2011) Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Res Treat 127:233\u2013241","journal-title":"Breast Cancer Res Treat"},{"key":"4736_CR13","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1200\/JCO.2010.33.4482","volume":"29","author":"SA Khan","year":"2011","unstructured":"Khan SA (2011) Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol 29:2132\u20132135","journal-title":"J Clin Oncol"},{"key":"4736_CR14","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/S1470-2045(13)70047-0","volume":"14","author":"JA Murphy","year":"2013","unstructured":"Murphy JA, Milner TD, O\u2019Donoghue JM (2013) Contralateral risk-reducing mastectomy in sporadic breast cancer. Lancet Oncol 14:e262\u2013e269","journal-title":"Lancet Oncol"},{"key":"4736_CR15","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-011-1914-x","volume":"18","author":"A Abbott","year":"2011","unstructured":"Abbott A, Rueth N, Pappas-Varco S et al (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol 18:3129\u20133136","journal-title":"Ann Surg Oncol"},{"key":"4736_CR16","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1245\/s10434-015-4442-2","volume":"22","author":"PR Portschy","year":"2015","unstructured":"Portschy PR, Abbott AM, Burke EE et al (2015) Perceptions of contralateral breast cancer risk: a prospective, longitudinal study. Ann Surg Oncol 22:3846\u20133852. \n                    https:\/\/doi.org\/10.1245\/s10434-015-4442-2","journal-title":"Ann Surg Oncol"},{"key":"4736_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","volume":"9","author":"Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists\u2019 Group","year":"2008","unstructured":"Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists\u2019 Group (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9:45\u201353","journal-title":"Lancet Oncol"},{"key":"4736_CR18","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"4736_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","volume":"11","author":"J Cuzick","year":"2010","unstructured":"Cuzick J, Sestak I, Baum M et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11:1135\u20131141","journal-title":"Lancet Oncol"},{"key":"4736_CR20","first-page":"855","volume":"8","author":"Y Chen","year":"1999","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855\u2013861","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4736_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-007-9709-2","volume":"110","author":"M Schaapveld","year":"2008","unstructured":"Schaapveld M, Visser O, Louwman WJ et al (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189\u2013197","journal-title":"Breast Cancer Res Treat"},{"key":"4736_CR22","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","volume":"27","author":"MK Graeser","year":"2009","unstructured":"Graeser MK, Engel C, Rhiem K et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27:5887\u20135892","journal-title":"J Clin Oncol"},{"key":"4736_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA Mccormack","year":"2006","unstructured":"Mccormack VA (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15:1159\u20131169. \n                    https:\/\/doi.org\/10.1158\/1055-9965.epi-06-0034","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4736_CR24","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/jnci\/djq239","volume":"102","author":"NF Boyd","year":"2010","unstructured":"Boyd NF, Martin LJ, Bronskill M et al (2010) Breast tissue composition and susceptibility to breast cancer. JNCI J. Nat. Cancer Inst 102:1224\u20131237. \n                    https:\/\/doi.org\/10.1093\/jnci\/djq239","journal-title":"JNCI J. Nat. Cancer Inst"},{"key":"4736_CR25","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/1055-9965.EPI-10-0769","volume":"19","author":"LA Habel","year":"2010","unstructured":"Habel LA, Capra AM, Achacoso NS et al (2010) Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev 19:2488\u20132495","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4736_CR26","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1158\/1055-9965.EPI-07-0458","volume":"16","author":"ES Hwang","year":"2007","unstructured":"Hwang ES, Miglioretti DL, Ballard-Barbash R et al (2007) Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev 16:2587\u20132593","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4736_CR27","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/cncr.30573","volume":"123","author":"A Raghavendra","year":"2017","unstructured":"Raghavendra A, Sinha AK, Le-Petross HT et al (2017) Mammographic breast density is associated with the development of contralateral breast cancer. Cancer 123:1935\u20131940","journal-title":"Cancer"},{"key":"4736_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3451","author":"ME Sandberg","year":"2013","unstructured":"Sandberg ME, Li J, Hall P et al (2013) Change of mammographic density predicts the risk of contralateral breast cancer\u2014a case-control study. Breast Cancer Res. \n                    https:\/\/doi.org\/10.1186\/bcr3451","journal-title":"Breast Cancer Res"},{"key":"4736_CR29","unstructured":"Breast Cancer Surveillance Consortium (\n                    http:\/\/breastscreening.cancer.gov\/\n                    \n                  ) (2016). National Cancer Institute, Applied Research Program"},{"key":"4736_CR30","volume-title":"Statistical Methods in Cancer Research","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. International Agency for Research on Cancer, Lyon"},{"key":"4736_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10549-016-4039-x","volume":"161","author":"M Chowdhury","year":"2017","unstructured":"Chowdhury M, Euhus D, Onega T et al (2017) A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat 161:153\u2013160. \n                    https:\/\/doi.org\/10.1007\/s10549-016-4039-x","journal-title":"Breast Cancer Res Treat"},{"key":"4736_CR32","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S (2000) Applied Logistic Regression, 2nd ed. Wiley, hoboken","DOI":"10.1002\/0471722146"},{"key":"4736_CR33","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2016","unstructured":"Development Core Team R (2016) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna"},{"key":"4736_CR34","unstructured":"Therneau TM (2015) A package for survival analysis in S. version 2.41-3. \n                    https:\/\/CRAN.R-project.org\/package=survival\n                    \n                   Accessed Nov 22 2017"},{"key":"4736_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) Modeling survival data: extending the cox model. Springer, Berlin"},{"key":"4736_CR36","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/S1470-2045(13)70047-0","volume":"14","author":"JA Murphy","year":"2013","unstructured":"Murphy JA, Milner TD, O\u2019Donoghue JM (2013) Contralateral risk-reducing mastectomy in sporadic breast cancer. Lancet Oncol 14:e262\u2013e269","journal-title":"Lancet Oncol"},{"issue":"3","key":"4736_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10549-007-9807-1","volume":"111","author":"K Innos","year":"2007","unstructured":"Innos K, Horn-Ross PL (2007) Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 111(3):531\u2013540. \n                    https:\/\/doi.org\/10.1007\/s10549-007-9807-1","journal-title":"Breast Cancer Res Treat"},{"key":"4736_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12957-015-0638-y","volume":"13","author":"NN Basu","year":"2015","unstructured":"Basu NN, Ross GL, Evans DG, Barr L (2015) The Manchester guidelines for contralateral risk-reducing mastectomy. World J Surg Oncol 13:237. \n                    https:\/\/doi.org\/10.1186\/s12957-015-0638-y","journal-title":"World J Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4736-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:06:13Z","timestamp":1589720773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4736"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4736-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}